Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Login 
Users Online :1274
Small font sizeDefault font sizeIncrease font size
Navigate Here
     My Preferences 
     Manuscript submission

 


This article has been cited by
1Holistic support coupled with prospective tracking reduces abandonment in childhood cancers: A report from India
Shalini Jatia,Maya Prasad,Amey Paradkar,Ameeta Bhatia,Gaurav Narula,Girish Chinnaswamy,Tushar Vora,Sanjay Gomle,Hari Sankaran,Shripad Banavali
Pediatric Blood & Cancer.2019;66(6)e27716
[DOI]
2Childhood cancer in India
Shuvadeep Ganguly,Sally Kinsey,Sameer Bakhshi
Cancer Epidemiology.2020;66(6)101679
[DOI]
3Post-induction Measurable Residual Disease Using Multicolor Flow Cytometry Is Strongly Predictive of Inferior Clinical Outcome in the Real-Life Management of Childhood T-Cell Acute Lymphoblastic Leukemia: A Study of 256 Patients
Prashant R. Tembhare,Gaurav Narula,Twinkle Khanka,Sitaram Ghogale,Gaurav Chatterjee,Nikhil V. Patkar,Maya Prasad,Yajamanam Badrinath,Nilesh Deshpande,Pratyusha Gudapati,Shefali Verma,Mahima Sanyal,Florence Kunjachan,Gunit Mangang,Sumeet Gujral,Shripad Banavali,Papagudi G. Subramanian
Frontiers in Oncology.2020;10(6)101679
[DOI]
4Outcomes and impact of minimal residual disease (MRD) in pediatric, adolescent and young adults (AYA) with acute lymphoblastic leukemia treated with modified MCP 841 protocol
Avinash Pandey,Shivali Ahlawat,Anjana Singh,Shivkant Singh,Krishna Murari,Raj Aryan
Cancer Research, Statistics, and Treatment.2020;3(2)183
[DOI]
5Comment on: The COVID-19 pandemic: A rapid global response for children with cancer from SIOP, COG, SIOP-E, SIOP-PODC, IPSO, PROS, CCI, and St Jude Global
Chetan Dhamne,Tushar Vora,Maya Prasad,Nirmalya Roy Moulik,Badira C. Parambil,Akanksha Chichra,Girish Chinnaswamy,Shripad Banavali,Gaurav Narula
Pediatric Blood & Cancer.2020;67(9)183
[DOI]
6Flow cytometric evaluation of CD38 expression levels in the newly diagnosed T-cell acute lymphoblastic leukemia and the effect of chemotherapy on its expression in measurable residual disease, refractory disease and relapsed disease: an implication for anti-CD38 immunotherapy
Prashant Ramesh Tembhare,Harshini Sriram,Twinkle Khanka,Gaurav Chatterjee,Devasis Panda,Sitaram Ghogale,Yajamanam Badrinath,Nilesh Deshpande,Nikhil V Patkar,Gaurav Narula,Bhausaheb Bagal,Hasmukh Jain,Manju Sengar,Navin Khattry,Shripad Banavali,Sumeet Gujral,Papagudi G Subramanian
Journal for ImmunoTherapy of Cancer.2020;8(1)e000630
[DOI]
  Site Map | What's new | Copyright and Disclaimer
  Online since 1st April '07
  2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow